ArticleFuture oncology (London, England)2025

A phase II study of lurbinectedin with or without avelumab in small cell carcinoma of the bladder (laser)-design and rationale.

Nicholas Simon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.